These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

377 related articles for article (PubMed ID: 23312053)

  • 1. A novel omega-3 free fatty acid formulation has dramatically improved bioavailability during a low-fat diet compared with omega-3-acid ethyl esters: the ECLIPSE (Epanova(®) compared to Lovaza(®) in a pharmacokinetic single-dose evaluation) study.
    Davidson MH; Johnson J; Rooney MW; Kyle ML; Kling DF
    J Clin Lipidol; 2012; 6(6):573-84. PubMed ID: 23312053
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Steady-state bioavailability of prescription omega-3 on a low-fat diet is significantly improved with a free fatty acid formulation compared with an ethyl ester formulation: the ECLIPSE II study.
    Offman E; Marenco T; Ferber S; Johnson J; Kling D; Curcio D; Davidson M
    Vasc Health Risk Manag; 2013; 9():563-73. PubMed ID: 24124374
    [TBL] [Abstract][Full Text] [Related]  

  • 3. A Novel ω-3 Acid Ethyl Ester Formulation Incorporating Advanced Lipid Technologies
    Lopez-Toledano MA; Thorsteinsson T; Daak A; Maki KC; Johns C; Rabinowicz AL; Sancilio FD
    Clin Ther; 2017 Mar; 39(3):581-591. PubMed ID: 28189364
    [TBL] [Abstract][Full Text] [Related]  

  • 4. A Single-dose, Comparative Bioavailability Study of a Formulation containing OM3 as Phospholipid and Free Fatty Acid to an Ethyl Ester Formulation in the Fasting and Fed States.
    Lapointe JF; Harvey L; Aziz S; Jordan H; Hegele RA; Lemieux P
    Clin Ther; 2019 Mar; 41(3):426-444. PubMed ID: 30799231
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Minimal food effect for eicosapentaenoic acid and docosahexaenoic acid bioavailability from omega-3-acid ethyl esters with an Advanced Lipid Technologies
    Lopez-Toledano MA; Thorsteinsson T; Daak AA; Maki KC; Johns C; Rabinowicz AL; Sancilio FD
    J Clin Lipidol; 2017; 11(2):394-405. PubMed ID: 28502496
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Omega-3 fatty acid exposure with a low-fat diet in patients with past hypertriglyceridemia-induced acute pancreatitis; an exploratory, randomized, open-label crossover study.
    Dunbar RL; Gaudet D; Davidson M; Rensfeldt M; Yang H; Nilsson C; Kvarnström M; Oscarsson J
    Lipids Health Dis; 2020 May; 19(1):117. PubMed ID: 32473640
    [TBL] [Abstract][Full Text] [Related]  

  • 7. A novel self-micro-emulsifying delivery system (SMEDS) formulation significantly improves the fasting absorption of EPA and DHA from a single dose of an omega-3 ethyl ester concentrate.
    Qin Y; Nyheim H; Haram EM; Moritz JM; Hustvedt SO
    Lipids Health Dis; 2017 Oct; 16(1):204. PubMed ID: 29037249
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Effects of a Self-micro-emulsifying Delivery System Formulation Versus a Standard ω-3 Acid Ethyl Ester Product on the Bioavailability of Eicosapentaenoic Acid and Docosahexaenoic Acid: A Study in Healthy Men and Women in a Fasted State.
    Maki KC; Palacios OM; Buggia MA; Trivedi R; Dicklin MR; Maki CE
    Clin Ther; 2018 Dec; 40(12):2065-2076. PubMed ID: 30454850
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The bioavailability and pharmacodynamics of different concentrations of omega-3 acid ethyl esters.
    Bryhn M; Hansteen H; Schanche T; Aakre SE
    Prostaglandins Leukot Essent Fatty Acids; 2006 Jul; 75(1):19-24. PubMed ID: 16806871
    [TBL] [Abstract][Full Text] [Related]  

  • 10. A Head-to-Head Comparison of a Free Fatty Acid Formulation of Omega-3 Pentaenoic Acids Versus Icosapent Ethyl in Adults With Hypertriglyceridemia: The ENHANCE-IT Study.
    Maki KC; Bays HE; Ballantyne CM; Underberg JA; Kastelein JJP; Johnson JB; Ferguson JJ
    J Am Heart Assoc; 2022 Mar; 11(6):e024176. PubMed ID: 35232215
    [TBL] [Abstract][Full Text] [Related]  

  • 11. In vitro dissolution behaviour and absorption in humans of a novel mixed l-lysine salt formulation of EPA and DHA.
    Manusama K; Balvers M; Diepeveen-de Bruin M; Headley L; Bosi R; Schwarm M; Witkamp R
    Prostaglandins Leukot Essent Fatty Acids; 2021 Jan; 164():102232. PubMed ID: 33360684
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The clinical relevance of omega-3 fatty acids in the management of hypertriglyceridemia.
    Backes J; Anzalone D; Hilleman D; Catini J
    Lipids Health Dis; 2016 Jul; 15(1):118. PubMed ID: 27444154
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Systemic Bioavailability and Dose Proportionality of Omega-3 Administered in Free Fatty Acid Form Compared With Ethyl Ester Form: Results of a Phase 1 Study in Healthy Volunteers.
    Offman E; Davidson M; Abu-Rashid M; Chai P; Nilsson C
    Eur J Drug Metab Pharmacokinet; 2017 Oct; 42(5):815-825. PubMed ID: 28116646
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Effects of Food on the Pharmacokinetics of Omega-3-Carboxylic Acids in Healthy Japanese Male Subjects: A Phase I, Randomized, Open-label, Three-period, Crossover Trial.
    Shimada H; Nilsson C; Noda Y; Kim H; Lundström T; Yajima T
    J Atheroscler Thromb; 2017 Sep; 24(9):980-987. PubMed ID: 28344197
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Bioavailability of marine n-3 fatty acid formulations.
    Dyerberg J; Madsen P; Møller JM; Aardestrup I; Schmidt EB
    Prostaglandins Leukot Essent Fatty Acids; 2010 Sep; 83(3):137-41. PubMed ID: 20638827
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Risk stratification by the "EPA+DHA level" and the "EPA/AA ratio" focus on anti-inflammatory and antiarrhythmogenic effects of long-chain omega-3 fatty acids.
    Rupp H; Wagner D; Rupp T; Schulte LM; Maisch B
    Herz; 2004 Nov; 29(7):673-85. PubMed ID: 15580322
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Bioequivalence of two omega-3 fatty acid ethyl ester formulations: a case of clinical pharmacology of dietary supplements.
    Galli C; Maggi FM; Risé P; Sirtori CR
    Br J Clin Pharmacol; 2012 Jul; 74(1):60-5. PubMed ID: 22242645
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Similar eicosapentaenoic acid and docosahexaenoic acid plasma levels achieved with fish oil or krill oil in a randomized double-blind four-week bioavailability study.
    Yurko-Mauro K; Kralovec J; Bailey-Hall E; Smeberg V; Stark JG; Salem N
    Lipids Health Dis; 2015 Sep; 14():99. PubMed ID: 26328782
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Bioavailability of long chain omega-3 polyunsaturated fatty acids from phospholipid-rich herring roe oil in men and women with mildly elevated triacylglycerols.
    Cook CM; Hallaråker H; Sæbø PC; Innis SM; Kelley KM; Sanoshy KD; Berger A; Maki KC
    Prostaglandins Leukot Essent Fatty Acids; 2016 Aug; 111():17-24. PubMed ID: 27151222
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Epanova(®) and hypertriglyceridemia: pharmacological mechanisms and clinical efficacy.
    Kataoka Y; Uno K; Puri R; Nicholls SJ
    Future Cardiol; 2013 Mar; 9(2):177-86. PubMed ID: 23463969
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 19.